J. Eugene Lee
Affiliations: | 2006 | Department of Biochemistry | University of Wisconsin, Madison, Madison, WI |
Google:
"J. Lee"Mean distance: 8.25 | S | N | B | C | P |
Parents
Sign in to add mentor| Ronald T. Raines | grad student | 2006 | UW Madison | |
| (Ribonuclease A homologs: Catalysis and cytotoxicity) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cho SI, Lim K, Hong S, et al. (2024) Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA. Cell. 187: 95-109.e26 |
| Geboers B, Meijer D, Counter W, et al. (2023) PSMA-PET in Addition to mpMRI and Biopsies to Select Prostate Cancer Patients for Focal Therapy. Bju International |
| Heo J, Lee H, Seog Y, et al. (2023) Cancer Prediction With Machine Learning of Thrombi From Thrombectomy in Stroke: Multicenter Development and Validation. Stroke |
| Lee J, Lim K, Kim A, et al. (2023) Prime editing with genuine Cas9 nickases minimizes unwanted indels. Nature Communications. 14: 1786 |
| Kim YH, Kim N, Okafor I, et al. (2023) Sniper2L is a high-fidelity Cas9 variant with high activity. Nature Chemical Biology |
| Kwon J, Kim M, Hwang W, et al. (2023) Extru-seq: a method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches. Genome Biology. 24: 4 |
| Doan P, Counter W, Papa N, et al. (2022) Synchronous versus independent reading of PSMA-PET and MRI to improve diagnosis for prostate cancer. Bju International |
| Kuraoka M, Curtis NC, Watanabe A, et al. (2022) Infant Antibody Repertoires during the First Two Years of Influenza Vaccination. Mbio. e0254622 |
| Huff JS, Díaz SA, Barclay MS, et al. (2022) Tunable Electronic Structure via DNA-Templated Heteroaggregates of Two Distinct Cyanine Dyes. The Journal of Physical Chemistry. C, Nanomaterials and Interfaces. 126: 17164-17175 |
| Lee JE, Raines RT. (2008) Ribonucleases as novel chemotherapeutics : the ranpirnase example. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 22: 53-8 |